PMID- 35464784
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2574-9870 (Electronic)
IS  - 2574-9870 (Linking)
VI  - 5
IP  - 4
DP  - 2022 Apr
TI  - Interinstitutional simulation of patients with COVID-19 during a remote 
      acute-care advanced pharmacy practice experience.
PG  - 442-449
LID - 10.1002/jac5.1596 [doi]
AB  - INTRODUCTION: Faculty and staff from Duquesne University and the University of 
      Pittsburgh Schools of Pharmacy created a simulation activity focused on the care 
      of critically ill patients with coronavirus disease 2019 (COVID-19). Students on 
      remote, short-term-care advanced pharmacy practice experiences (APPE) rotations 
      from both universities worked in comingled teams and completed two educational 
      electronic health record reviews, complex simulation sessions, and debriefs. 
      Individually, students completed two educational electronic health record reviews 
      and verbal patient presentations before and after the simulation sessions. 
      OBJECTIVES: Evaluate the effects of a simulation activity during a remote 
      short-term-care APPE on student confidence and knowledge surrounding the care of 
      a critically ill patient with COVID-19. METHODS: Student knowledge surrounding 
      COVID-19 short-term-care treatment principles was assessed through 
      pre-/postcase-based multiple-choice examinations and an intermittent clinical 
      examination (ICE). Student confidence and perceptions were gathered through 
      anonymous pre-/postsurveys. The written examination and patient presentation 
      recordings were compared from baseline to the final assessment using the Wilcoxon 
      signed-rank test. RESULTS: In total, 92 students participated in the activity. 
      There was a statistically significant improvement from baseline to the final 
      assessment (preassessment median [interquartile range (IQR)]: 55.3% [50%-60.5%]; 
      postassessment median [IQR]: 68.4 [60.5%-73.7%]; P < .001) on the written 
      examination. ICE total scores improved from baseline (preassessment median 
      [range]: 33 [28-36] vs postassessment median [range]: 36.5 [29.5-43.52]; 
      P = .004) as well as the objective (P < .001), plan (P < .001), and monitoring 
      (P < .001) subdomain scores. Student confidence reported on surveys improved from 
      baseline in all domains. CONCLUSION: Remote simulation sessions improve student 
      knowledge and confidence and provide an opportunity for students to experience 
      caring for patients with COVID-19 in a safe environment. Collaboration between 
      schools of pharmacy can be successfully employed to leverage resources and 
      expertise to expand opportunities for students.
CI  - (c) 2022 Pharmacotherapy Publications, Inc.
FAU - Perry, Michael W
AU  - Perry MW
AUID- ORCID: 0000-0002-7052-7807
AD  - Duquesne University School of Pharmacy Pittsburgh Pennsylvania USA.
FAU - Kobulinsky, Lawrence R
AU  - Kobulinsky LR
AD  - University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA.
FAU - Seybert, Amy L
AU  - Seybert AL
AD  - University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA.
FAU - Kreider, Madeline S
AU  - Kreider MS
AD  - University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA.
FAU - Williams, Victoria
AU  - Williams V
AD  - University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA.
FAU - Smithburger, Pamela L
AU  - Smithburger PL
AD  - University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA.
LA  - eng
PT  - Journal Article
DEP - 20220124
PL  - United States
TA  - J Am Coll Clin Pharm
JT  - Journal of the American College of Clinical Pharmacy : JACCP
JID - 101723133
PMC - PMC9015639
OTO - NOTNLM
OT  - COVID-19
OT  - interactive learning
OT  - multiinstitutional systems
OT  - online learning
OT  - patient simulation
OT  - pharmacy education
OT  - remote education
COIS- Amy Seybert serves on the board of directors of the Accreditation Council for 
      Pharmacy Education (ACPE). This article does not represent ACPE's or the board of 
      directors' opinions or views. She also receives consulting fees in her role as a 
      consultant for Pfizer. All other authors have no relevant conflicts of interest.
EDAT- 2022/04/26 06:00
MHDA- 2022/04/26 06:01
PMCR- 2022/01/24
CRDT- 2022/04/25 05:38
PHST- 2021/08/11 00:00 [received]
PHST- 2021/11/05 00:00 [revised]
PHST- 2021/11/23 00:00 [accepted]
PHST- 2022/04/25 05:38 [entrez]
PHST- 2022/04/26 06:00 [pubmed]
PHST- 2022/04/26 06:01 [medline]
PHST- 2022/01/24 00:00 [pmc-release]
AID - JAC51596 [pii]
AID - 10.1002/jac5.1596 [doi]
PST - ppublish
SO  - J Am Coll Clin Pharm. 2022 Apr;5(4):442-449. doi: 10.1002/jac5.1596. Epub 2022 
      Jan 24.